Ruxolitinib versus best available therapy for ET intolerant or resistant to hydroxycarbamide in a randomised trial
- Submitting institution
-
Queen's University of Belfast
- Unit of assessment
- 2 - Public Health, Health Services and Primary Care
- Output identifier
- 134254333
- Type
- D - Journal article
- DOI
-
10.1182/blood-2017-05-785790
- Title of journal
- Blood
- Article number
- -
- First page
- 1889
- Volume
- 130
- Issue
- 17
- ISSN
- 0006-4971
- Open access status
- Compliant
- Month of publication
- August
- Year of publication
- 2017
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
20
- Research group(s)
-
-
- Citation count
- 54
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to the conception and design of the study, organisation and conduct of the study carrying out the study, analysis and interpretation of study data and helped draft the output.
- Non-English
- No
- English abstract
- -
